Patents by Inventor Wenke Zheng

Wenke Zheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230113539
    Abstract: Provided are a traditional Chinese medicine for dispersing lung qi and detoxicating, a preparation method therefor, use thereof, and an analysis method. The traditional Chinese medicine contains a traditional Chinese medicine active extract. The active extract is composed of a first extract and, a second extract, herein the first extract is a water extract or an alcohol-water extract of ephedra, bitter apricot seed, raw gypsum, coix seed, rhizome of swordlike atractylodes, patchouli, Polygonum cuspidatum, verbena, reed rhizome, lepidium seed, pummelo peel, and artemisia annua, the second extract is a water extract or an alcohol-water extract of licorice, and the first extract and the second extract are separately obtained. This traditional Chinese medicine may be used for treating coronavirus diseases, such as novel coronavirus pneumonia.
    Type: Application
    Filed: March 17, 2021
    Publication date: April 13, 2023
    Inventors: Boli ZHANG, Qingquan LIU, Xiumei GAO, Junhua ZHANG, Xinbo SONG, Lei ZHANG, Yi WANG, Fengwen YANG, Wenke ZHENG, Tao WANG, Yuefei WANG, Han ZHANG, Yuhong HUANG, Ping WANG, Erwei LIU, Dailin LIU, Jingze ZHANG, Ming HUANG
  • Patent number: 9211310
    Abstract: The present invention relates to a use of Chinese medicine composition in preparation of medicine for secondary prevention of myocardial infarction. Said Chinese medicine composition is prepared from a formula comprising the crude drugs by the following weight percentages: Radix Astragali 22.2%˜66.8%, Radix Salviae Miltiorrhizae 11.6%˜33.4%, Radix Notoginseng 2.5%˜13.5%, and Lignum Dalbergiae Odoriferae 14.5%˜44.3%.
    Type: Grant
    Filed: June 28, 2011
    Date of Patent: December 15, 2015
    Assignee: TASLY PHARMACEUTICAL GROUP CO., LTD
    Inventors: Boli Zhang, Hongcai Shang, Chen Yao, Baoyan Liu, Weiliang Weng, Yuxia Zhao, Guohua Dai, Xiumei Gao, Ming Ren, Junhua Zhang, Hongbo Cao, Jingyuan Mao, Xuejun Hu, Zhisheng Jin, Junping Zhang, Yiyu Cheng, Xijun Yan, Jiazhen Qu, Hui Wang, Hongjuan Xu, Wenke Zheng
  • Publication number: 20130209590
    Abstract: The present invention relates to a use of Chinese medicine composition in preparation of medicine for secondary prevention of myocardial infarction. Said Chinese medicine composition is prepared from a formula comprising the crude drugs by the following weight percentages: Radix Astragali 22.2%˜66.8%, Radix Salviae Miltiorrhizae 11.6%˜33.4%, Radix Notoginseng 2.5%˜13.5%, and Lignum Dalbergiae Odoriferae 14.5%˜44.3%.
    Type: Application
    Filed: June 28, 2011
    Publication date: August 15, 2013
    Applicant: TASLY PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Boli Zhang, Hongcai Shang, Chen Yao, Baoyan Liu, Weiliang Weng, Yuxia Zhao, Guohua Dai, Xiumei Gao, Ming Ren, Junhua Zhang, Hongbo Cao, Jingyuan Mao, Xuejun Hu, Zhisheng Jin, Junping Zhang, Yiyu Cheng, Xijun Yan, Jiazhen Qu, Hui Wang, Hongjuan Xu, Wenke Zheng